Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Role of MMP-9, TIMP-1 as Markers of Lung Imaging and Functional Abnormality of COVID-19

NCT05844215 is registered in ClinicalTrials.gov with Universitas Airlangga as lead sponsor.

NCT NCT05844215
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05844215 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Role of MMP-9, TIMP-1 as Markers of Lung Imaging and Functional Abnormality of COVID-19
Lead sponsor
Universitas Airlangga
Phase
Observational
Overall status
Completed
Start date
March 15, 2021
Completion date
July 20, 2022
Enrollment
78 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19, extracellular matrix alteration, pulmonary infection